Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment

RNA interference (RNAi) represents a promising strategy for identification and validation of putative therapeutic targets and for treatment of a myriad of important human diseases including cancer. However, the effective systemic in vivo delivery of small interfering RNA (siRNA) to tumors remains a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Proc Natl Acad Sci U S A
Asıl Yazarlar: Zhu, Xi, Xu, Yingjie, Solis, Luisa M., Tao, Wei, Wang, Liangzhe, Behrens, Carmen, Xu, Xiaoyang, Zhao, Lili, Liu, Danny, Wu, Jun, Zhang, Ning, Wistuba, Ignacio I., Farokhzad, Omid C., Zetter, Bruce R., Shi, Jinjun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2015
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485147/
https://ncbi.nlm.nih.gov/pubmed/26056316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1505629112
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller